W. Chris Taylor
Netherlands Comprehensive Cancer Organisation(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research
Most-Cited Works
- → Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial(2018)604 cited
- → Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial(2019)438 cited
- → Geriatric Assessment-Identified Deficits in Older Cancer Patients With Normal Performance Status(2015)226 cited
- → Feasibility of geriatric assessment in community oncology clinics(2014)112 cited
- Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.(1985)
- → Recent Advances(2010)23 cited
- → Repeated Cycles with 72-Hour Continuous Infusion Interleukin-2 in Kidney Cancer and Melanoma(2004)18 cited
- → High-Dose Continuous Infusion Plus Pulse Interleukin-2 and Famotidine in Melanoma(2004)15 cited
- Adjuvant chemotherapy of breast cancer in the older patient.(2010)
- → Correlation Between Development of Pulmonary Edema and Response of Pulmonary Metastases of Metastatic Melanoma and Kidney Cancer to High-Dose Continuous-Infusion Interleukin-2(2005)3 cited